Menu UF Health Home Menu
 

Pilot Funding

SECIM is committed to offering pilot and feasibility funding for projects that support the advancement of metabolomics.  Please add your name to our distribution list to be notified about upcoming opportunities.

Pilot and Feasibility Projects

The deadline for submitting applications for the 2014 SECIM Pilot & Feasibility Program was March 15, 2014.

The 2014 call for pilot & feasibility projects is now closed.  SECIM will be requesting applications for 2015 Pilot & Feasibility in early 2015, with a likely submission deadline of March 15, 2015.

The goal of this initiative is to enhance metabolomics research by providing support for investigators new to the field, the development of new teams and partnerships, and high-risk/high-impact research.  Applicants must demonstrate that proposed pilot projects will provide critical preliminary data to support new extramural grant applications.  Investigators new to the field of metabolomics are especially encouraged to apply.

Investigators are required to complete all elements contained in the “Application Instructions & Cover Sheet” and “Application Forms” files listed below.  Forms (in the zip folders) must be submitted in the NIH-approved PDF format provided.

SECIM provides state-of-the-art metabolomics services to users in all areas of biomedical and biological sciences. Four cores provide services and develop emerging technologies for the SECIM pipeline, giving users the flexibility to choose the best approach for a particular problem.  Please contact info@secim.ufl.edu before budgeting for SECIM services:

2014 Funded Projects

  • Dr. Lisa Ainsworth, University of Illinois
    “Metabolite profiling of ozone stress in maize”
  • Dr. Sanjoy Bhattacharya, University of Miami
    “Imaging lipids in the control and glaucomatous Trabecular meshwork”
  • Dr. Samantha Brooks, University of Florida
    “Metabolomic diagnostics in the horse”
  • Dr. Rhonda Cooper-DeHoff, University of Florida
    “A targeted pharmacometabolic investigation of the acylcarnitine pathway and incident impaired fasting glucose”
  • Dr. Irwin Kurland, Yeshiva University, Einstein Stable Isotope and Metabolomics Core Facility
    “MALDI visualization and IROA profiling of lipin 1 regulation of skeletal muscle metabolism”
  • Dr. Amy Lane, University of North Florida
    “Chemical communication signals as modulators of microbial metabolism”
  • Dr. Stuart McDaniel, University of Florida
    “Sexual antagonism in exuded non-volatile metabolites in C. purpureus”
  • Dr. Ami Raval, University of Miami
    “Nicotene alters brain oxidative metabolism”
  • Dr. Kelly Rice, University of Florida
    “Utilization of a global metabolomics approach to probe the effects of nitric oxide on physiology of the pathogen Staphylococcus aureus”
  • Dr. Weihong Tan, University of Florida
    “Aptamer-conjugated nanostructures for MALDI-MS detection and identification of metabolites”
  • Dr. Thomas Walsh, Cornell University
    “Metabolomic-based investigation on the effects of flucononazole in Candida albicans under planktonic and biofilm conditions”

For additional pilot funding information provided by SECIM’s five national NIH metabolomics consortium partners, please visit their websites: